The Esprit™ BTK System is a breakthrough innovation, pioneering a new standard of care by delivering superior efficacy***, without the drawbacks of traditional therapies2
† Primary Safety Endpoint is Freedom from Major Adverse Limb Event (6 mo) + Peri-operative Death (30 days)
*Results reported as CD-TLR within 1 year
**Data from lesion length terciles post hoc analysis
***Primary efficacy endpoint is a composite of limb salvage and primary patency at 1 year
MAT-2405960 v1.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0